Martin Jäckel10:27
Thank you very much, Thomas. Ladies and gentlemen, esteemed shareholders, please allow me to briefly introduce myself. My name is Martin Jäckel, and I have been the CFO of Bilfinger since July 1, 2022. Since my start — one could even say since 1989 in the then Bilfinger und Berger Bauaktiengesellschaft — I have been able to accompany and shape the development of the company both domestically and abroad. In the autumn of 2010, I moved from the construction business to industrial services as divisional management responsibility, which at that time accounted for about three-quarters of today's portfolio. I bring with me extensive experience in the service and project business, and I am very pleased to be able to help shape the next phase of the company's development in a key role.
Bilfinger's business model has once again proven robust in turbulent times. Ongoing supply chain disruptions, the war in Ukraine, and inflation are presenting our customers with considerable challenges. Our core competence — increasing efficiency and sustainability for our customers — is particularly in demand in a volatile market environment. This is reflected in our business figures.
The order intake of the Bilfinger Group increased by 15 percent in fiscal year 2022 to more than 4.6 billion euros. All three segments of the Group recorded positive development. The order backlog increased by 9 percent to 3.2 billion euros. The order intake-to-revenue ratio stood at 1.07.
Group revenue also grew by 15 percent to 4.3 billion euros, thereby reaching the pre-crisis level of 2019 again. Gross profit increased by 13 percent to 437 million euros, driven primarily by the increased revenue. The gross margin based on revenue was 10.1 percent. Selling and administrative expenses increased disproportionately by only 6 percent to 308 million euros.
Bilfinger achieved an EBITA of 75 million euros in the reporting year. In the previous year, it was 121 million euros. The significant decline is primarily due to the increase in special effects, which amounted to 65 million euros. Without these special effects, EBITA would have been 140 million euros and would thus have slightly increased compared to the previous year. The majority of the special effects related to provisions of 62 million euros for the efficiency program launched in November 2022. This program enables us to achieve savings of 55 million euros per year in the future. After deducting reinvestment in the training and further education of our employees, we improve the EBITA margin by approximately one percentage point.
In summary, the 2022 fiscal year resulted in an EBITA margin of 1.8 percent, or an adjusted EBITA margin of 3.2 percent excluding special effects. This is still slightly below the previous year's values. However, we had benefited considerably at that time from book gains from property and real estate sales amounting to 30 million euros. This item was significantly lower in 2022 at 10 million euros. The difference was more than offset by improved operating results.
Ladies and gentlemen, one of the most important key figures for the CFO is free cash flow, as it shows how successful we are at actually converting earnings into cash. Primarily through improvements in working capital, we increased this value to 136 million euros in the past fiscal year. It should be noted that in the previous year, we had tax refund inflows of 29 million euros as well as inflows from real estate sales of 57 million euros. In the reporting year, these one-time effects were more than offset by significantly increased operating cash flows. Furthermore, net investments in 2022 were 30 million euros compared to minus 2 million in the previous year. Dividends totaling 196 million euros and 100 million euros for the now completed share buyback program were paid out. Net liquidity including lease liabilities decreased to 145 million euros.
Allow me at this point to briefly review the development in our three business fields. In the Engineering and Maintenance Europe segment, order intake increased by 14 percent to 2.9 billion euros, driven by increased new framework contracts as well as projects to improve customer efficiency and sustainability. Revenue increased, supported by a strong season for major industrial plant overhauls — so-called turnarounds — in Scandinavia as well as increased demand in oil and gas.
The order intake-to-revenue ratio stood at 1.05. In the EBITA of this segment, special effects of 36 million euros are included. These comprise not only provisions for the efficiency program of 30 million euros but also expenses for the withdrawal from the Russia business of 6 million euros. EBITA for the reporting year was therefore 105 million euros, corresponding to an EBITA margin of 3.8 percent. Excluding special effects, EBITA amounted to 140 million euros with an adjusted EBITA margin of 5.0 percent.
In the Engineering and Maintenance International segment, order intake increased by 31 percent to 833 million euros. The strong increase resulted largely from maintenance and repair contracts for customers in North America. This demonstrates that the strategic reorientation undertaken in 2021 continues to have its effect, deploying our maintenance and repair know-how increasingly in North America. Revenue grew by 44 percent to 798 million euros, resulting in an order intake-to-revenue ratio of 1.04.
EBITA improved but remained negative at minus 8 million euros. Special effects were 3 million euros. The EBITA margin was minus 1.0 percent. Adjusted for special effects, EBITA improved to minus 5.3 million euros. The negative result is primarily due to legacy contracts in one business area that will no longer be offered by us in this form going forward. As explained at the Capital Markets Day, it is an integral part of our strategy to reduce risk in the project business and to reduce the share of projects in total revenue from 35 percent to 20 percent. This will primarily be reflected in this segment and significantly contribute to earnings improvement.
In the Technologies segment, order intake increased by 13 percent to 672 million euros, particularly in the pharma sector. Revenue increased on this basis by 6 percent to 592 million euros. The order intake-to-revenue ratio was 1.14. EBITA for the segment was 8 million euros, including special effects of 9 million euros. The EBITA margin was 1.4 percent. Adjusted for special effects, EBITA was 18 million euros with an adjusted EBITA margin of 3.0 percent.
The Group result decreased from 130 million euros to 28 million euros. Several effects contributed to this, including the provision of 62 million euros for the efficiency program, the loss of positive interest effects from tax refunds in the previous year, as well as the loss of these tax refunds themselves. On an adjusted basis, the Group result stood at 82 million euros and was thus only slightly below the previous year's value of 89 million euros.
Our share started the new stock market year with a closing price on December 30, 2021, of 29.90 euros. The profits generated in 2021 enabled us, on the one hand, to pay a special dividend of 3.75 euros per share in addition to the regular dividend of 1 euro per share after the Annual General Meeting on May 11, 2022. On the other hand, as authorized by you at last year's Annual General Meeting, we conducted an additional share buyback program. From July to November, we repurchased approximately 3.5 million of our own shares, corresponding to 8.55 percent of Bilfinger SE's share capital. For this, we spent 100 million euros. The repurchased shares were cancelled on March 20, 2023, with the exception of a residual holding of 200,000 shares.
During the year, the share price exhibited significant volatility and moved predominantly in a range between 26 and 30 euros. The year closed at a price of 27.08 euros. Thus, the total shareholder return — the sum of price performance and dividend payments — was approximately 7 percent. For comparison, the SDAX, in which our share is listed, gained 27 percent over the same period. In the first months of 2023, the Bilfinger share price rose steadily, reaching a level of approximately 38 euros.
Ladies and gentlemen, you can see that Bilfinger is on a good path. With our revised strategy and the efficiency program anchored therein, we have identified the right levers to make our company even more successful in the future. We also want to appropriately share in the positive operating development of Bilfinger with you this year. Therefore, we propose to you today a dividend of 1.30 euros per share. This corresponds to a dividend yield on the year-end closing price of 4.8 percent. The payout ratio based on adjusted Group results is approximately 60 percent, placing it at the upper end of the range of our dividend policy, which provides for a payout of 40 to 60 percent of adjusted Group results.
Together with the revised strategy, we also presented new medium-term targets in February. By 2024, we aim to achieve an EBITA margin of at least 5 percent. In the medium term, that is in the years 2025 to 2027, the EBITA margin will further increase but only to a level of 6 to 7 percent. Organic revenue growth will outpace market growth and average 4 to 5 percent per year. On this basis, we will continuously increase the Group result. A clear goal is to increase the dividend year after year, while carefully maintaining a solid financial position. It remains our objective to achieve an investment-grade credit rating in the future.
In 2022, we renegotiated a syndicated revolving credit facility with our core banks, expanding our previous credit line from 250 million euros to 300 million euros. The availability of funds is firmly committed until December 2027. The credit facility is currently not drawn upon.
Valued shareholders, today we ask for your approval on two capital reserve resolutions for capital measures. Under items 8 and 9 of the agenda, the Executive Board and Supervisory Board propose granting a new authorization to repurchase up to 10 percent of share capital. Under item 10, we request your approval to cancel the existing authorized capital 2023 and to create a new authorized capital 2023 against cash and/or non-cash contributions. This instrument gives us the possibility, with Supervisory Board approval, to quickly and flexibly realize equity financing when necessary and in the company's interest.
Ladies and gentlemen, I thank you for your attention and now hand the word back to Thomas.